BTIG Research reiterated their hold rating on shares of Transenterix (NYSEAMERICAN:TRXC) in a research note issued to investors on Monday morning.

Several other brokerages have also commented on TRXC. Ladenburg Thalmann Financial Services set a $5.00 price target on shares of Transenterix and gave the stock a buy rating in a report on Friday, October 20th. Stifel Nicolaus boosted their price target on shares of Transenterix from $3.75 to $4.00 and gave the stock a buy rating in a report on Tuesday, October 31st. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus target price of $2.61.

Shares of Transenterix (NYSEAMERICAN:TRXC) opened at $2.03 on Monday. Transenterix has a 1-year low of $0.45 and a 1-year high of $5.00.

In other Transenterix news, CFO Joseph P. Slattery sold 333,000 shares of Transenterix stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $2.93, for a total transaction of $975,690.00. Following the sale, the chief financial officer now owns 440,974 shares of the company’s stock, valued at approximately $1,292,053.82. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Joseph P. Slattery sold 529,609 shares of Transenterix stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $2.80, for a total transaction of $1,482,905.20. Following the sale, the chief financial officer now directly owns 440,974 shares in the company, valued at approximately $1,234,727.20. The disclosure for this sale can be found here. In the last three months, insiders sold 1,462,609 shares of company stock valued at $4,666,595.

An institutional investor recently raised its position in Transenterix stock. Ladenburg Thalmann Financial Services Inc. grew its holdings in shares of Transenterix Inc (NYSEAMERICAN:TRXC) by 87.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 79,150 shares of the medical instruments supplier’s stock after purchasing an additional 37,000 shares during the quarter. Ladenburg Thalmann Financial Services Inc. owned approximately 0.05% of Transenterix worth $113,000 at the end of the most recent quarter.

TRADEMARK VIOLATION WARNING: This report was originally posted by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.watchlistnews.com/transenterix-trxc-earns-hold-rating-from-btig-research/1775321.html.

Transenterix Company Profile

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with MarketBeat.com's FREE daily email newsletter.